Technical Analysis for CARA - Cara Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 23.92 7.75% 1.72
CARA closed up 7.75 percent on Thursday, September 20, 2018, on 2.08 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CARA trend table...

Date Alert Name Type % Chg
Sep 20 New 52 Week Closing High Bullish 0.00%
Sep 20 180 Bullish Setup Bullish Swing Setup 0.00%
Sep 20 Expansion Breakout Bullish Swing Setup 0.00%
Sep 20 Pocket Pivot Bullish Swing Setup 0.00%
Sep 20 New 52 Week High Strength 0.00%
Sep 20 Stochastic Reached Overbought Strength 0.00%
Sep 20 Upper Bollinger Band Walk Strength 0.00%
Sep 20 Above Upper BB Strength 0.00%
Sep 20 Overbought Stochastic Strength 0.00%
Sep 20 Upper Bollinger Band Touch Strength 0.00%

Older signals for CARA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat pain. Its products include intravenous CR845 that has completed Phase II clinical trials for the treatment of acute postoperative pain in adult patients; Oral CR845, which is in Phase I clinical trials to treat acute and chronic pain; and CR701 that is in preclinical trials for treating neuropathic and inflammatory pain. The company was founded in 2004 and is based in Shelton, Connecticut.
Is CARA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.01
52 Week Low 11.12
Average Volume 770,629
200-Day Moving Average 15.3809
50-Day Moving Average 19.5898
20-Day Moving Average 20.5015
10-Day Moving Average 21.463
Average True Range 0.9514
ADX 27.89
+DI 33.0555
-DI 8.0111
Chandelier Exit (Long, 3 ATRs ) 21.1558
Chandelier Exit (Short, 3 ATRs ) 20.7342
Upper Bollinger Band 23.1717
Lower Bollinger Band 17.8313
Percent B (%b) 1.14
BandWidth 26.048826
MACD Line 0.9697
MACD Signal Line 0.67
MACD Histogram 0.2997
Fundamentals Value
Market Cap 779.33 Million
Num Shares 32.6 Million
EPS -2.28
Price-to-Earnings (P/E) Ratio -10.49
Price-to-Sales 424.16
Price-to-Book 3.54
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.56
Resistance 3 (R3) 26.30 25.15 26.12
Resistance 2 (R2) 25.15 24.48 25.29 25.97
Resistance 1 (R1) 24.54 24.07 24.85 24.80 25.83
Pivot Point 23.39 23.39 23.55 23.53 23.39
Support 1 (S1) 22.78 22.72 23.09 23.04 22.01
Support 2 (S2) 21.63 22.31 21.77 21.87
Support 3 (S3) 21.02 21.63 21.72
Support 4 (S4) 21.28